Focused on Women’s Health, CureMetrix AI-based cmAngio™ was highlighted in the July 2021 edition of DOTmed HealthCareBusiness News. cmAngio “represents the potential to screen 40 million women a year for heart disease in the U.S. alone,” with AI that maximizes the mammogram for both breast cancer and heart disease detection.
![Dotmed 2](https://blog.curemetrix.com/hs-fs/hubfs/Dotmed%202.jpg?width=585&name=Dotmed%202.jpg)
![Dotmed 1](https://blog.curemetrix.com/hs-fs/hubfs/Dotmed%201.jpg?width=551&name=Dotmed%201.jpg)